{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:07:01Z","timestamp":1790611621264,"version":"4.1.0"},"reference-count":14,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.3960\/jslrt.22017","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T04:07:31Z","timestamp":1669608451000},"page":"238-241","source":"Crossref","is-referenced-by-count":3,"title":["An experience with ibrutinib monotherapy for Richter\u2019s syndrome isolated in the central nervous system"],"prefix":"10.3960","volume":"62","author":[{"given":"Yuma","family":"Nato","sequence":"first","affiliation":[{"name":"Department of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiki","family":"Nagaharu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Yabu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Sawaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Shiotani","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokkaichi Municipal Hospital, Yokkaichi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Parikh SA, Kay NE, Shanafelt TD. How we treat Richter syndrome. Blood. 2014; 123: 1647-1657.","DOI":"10.1182\/blood-2013-11-516229"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Rossi D, Spina V, Deambrogi C <i>et al.<\/i> The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood. 2011; 117: 3391-3401.","DOI":"10.1182\/blood-2010-09-302174"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Xu L, Song JC, Sun XH <i>et al.<\/i> Richter\u2019s syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: A case report and literature review. Medicine (Baltimore). 2018; 97: e12701.","DOI":"10.1097\/MD.0000000000012701"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Tsang M, Shanafelt TD, Call TG <i>et al.<\/i> The efficacy of ibrutinib in the treatment of Richter syndrome. Blood. 2015; 125: 1676-1678.","DOI":"10.1182\/blood-2014-12-610782"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Giri S, Hahn A, Yaghmour G, Martin MG. Ibrutinib has some activity in Richter\u2019s syndrome. Blood Cancer J. 2015; 5: e277.","DOI":"10.1038\/bcj.2014.98"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Grommes C, Pastore A, Palaskas N <i>et al.<\/i> Ibrutinib unmasks critical role of Bruton tyrosine kinase in primary CNS lymphoma. Cancer Discov. 2017; 7: 1018-1029.","DOI":"10.1158\/2159-8290.CD-17-0613"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Soussain C, Choquet S, Blonski M <i>et al.<\/i> Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: final analysis of the phase II \u2018proof-of-concept\u2019 iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network. Eur J Cancer. 2019; 117: 121-130.","DOI":"10.1016\/j.ejca.2019.05.024"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Yu H, Kong H, Li C <i>et al.<\/i> Bruton\u2019s tyrosine kinase inhibitors in primary central nervous system lymphoma-evaluation of anti-tumor efficacy and brain distribution. Transl Cancer Res. 2021; 10: 1975-1983.","DOI":"10.21037\/tcr-21-50"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Bernard S, Goldwirt L, Amorim S <i>et al.<\/i> Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse. Blood. 2015; 126: 1695-1698.","DOI":"10.1182\/blood-2015-05-647834"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Tucker DL, Naylor G, Kruger A <i>et al.<\/i> Ibrutinib is a safe and effective therapy for systemic mantle cell lymphoma with central nervous system involvement - a multi-centre case series from the United Kingdom. Br J Haematol. 2017; 178: 327-329.","DOI":"10.1111\/bjh.14122"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Ramasamy I, Brisco M, Morley A. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J Clin Pathol. 1992; 45: 770-775.","DOI":"10.1136\/jcp.45.9.770"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Delabie J, Tierens A, Wu G, Weisenburger DD, Chan WC. Lymphocyte predominance Hodgkin\u2019s disease: lineage and clonality determination using a single-cell assay. Blood. 1994; 84: 3291-3298.","DOI":"10.1182\/blood.V84.10.3291.3291"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Reed TJ, Reid A, Wallberg K, O\u2019Leary TJ, Frizzera G. Determination of B-cell clonality in paraffin-embedded lymph nodes using the polymerase chain reaction. Diagn Mol Pathol. 1993; 2: 42-49.","DOI":"10.1097\/00019606-199303000-00007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Dimou M, Bitsani A, Roumelioti M <i>et al.<\/i> Richter\u2019s transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood-brain barrier be a disease \u201csanctuary\u201d during venetoclax treatment? Clin Case Rep. 2021; 9: 2249-2253.","DOI":"10.1002\/ccr3.4002"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/4\/62_22017\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T04:53:33Z","timestamp":1672462413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/4\/62_22017\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.22017","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22017"}}